Drug Delivery Trends examines a drift in the pharmaceutical field across the wide range of dosage forms, drug delivery systems (micro and nanoparticulate), at the regulatory front and on new types of therapies in the market. This volume additionally covers the challenges on drug delivery systems in terms of preclinical and current ways of determining quality and the options to solve the challenges associated with this. Most small-medium scale industries and academics struggle with initial regulatory challenges so a detailed discussion on regulatory trend covers the necessary basic understanding of regulatory procedures and provides the required guidance.
The series Expectations and Realities of Multifunctional Drug Delivery Systems examines the fabrication, optimization, biological aspects, regulatory and clinical success of wide range of drug delivery carriers. This series reviews multifunctionality and applications of drug delivery systems, industrial trends, regulatory challenges and in vivo success stories. Throughout the volumes discussions on diverse aspects of drug delivery carriers, such as clinical, engineering, and regulatory, facilitate insight sharing across expertise area and form a link for collaborations between industry-academic scientists and clinical researchers.
Expectations and Realities of Multifunctional Drug Delivery Systems connects formulation scientists, regulatory experts, engineers, clinical experts and regulatory stake holders. The wide scope of the book ensures it as a valuable reference resource for researchers in both academia and the pharmaceutical industry who want to learn more about drug delivery systems.
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Table of Contents
1. Bioactive hybrid nanowires: a new in trend for site-speci?c drug delivery and targetingA.R. FERNANDES, J. DIAS-FERREIRA, M.C. TEIXEIRA, A.A.M. SHIMOJO, PATR�CIA SEVERINO, A.M. SILVA, RANJITA SHEGOKAR, AND ELIANA B. SOUTO
2. Opportunities and challenges of 3D-printed pharmaceutical dosage forms
ADAM PROCOPIO AND DIVYA TEWARI
3. Marketing authorization and licensing of medicinal products in EU: Regulatory aspects
MUHANED AL-HINDAWI
4. Clinical considerations on micro- and nanodrug delivery systems
PRAMIL TIWARI, VIVEK RANJAN SINHA, AND RANDEEP KAUR
5. Nanoparticulate treatments for oral delivery
ROHIT C. GHAN
6. Pharmaceutical mini-tablets: a revived trend
VENKAT TUMULURI
7. Liquid crystalline drug delivery systems
LUCIANA NALONE, CONRADO MARQUES, SALVANA COSTA, ELIANA B. SOUTO, AND PATR�CIA SEVERINO
8. Amorphous drug stabilization using mesoporous materials
DANILLO F.M.C. VELOSO, MATTHIAS M. KNOPP, AND KORBINIAN L?OBMANN
9. "Quality� of pharmaceutical products for human usedunderlying concepts and required practices
SAEED A. QURESHI
10. Optimizing intraperitoneal drug delivery: pressurized intraperitoneal aerosol chemotherapy (PIPAC)
M.A. REYMOND AND A. K?ONIGSRAINER
11. Upscaling and GMP production of pharmaceutical drug delivery systems
NAZENDE G?UNDAY T?URELI AND AKIF EMRE T?URELI
Authors
Ranjita Shegokar Postdoctoral Researcher, Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics, Free University of Berlin, Germany.Ranjita Shegokar holds a Ph.D. degree in Pharmaceutical Technology from the SNDT University, India, and has been a postdoctoral researcher in the Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics at the Free University of Berlin, Germany. Currently, she serves as Chief Scientific Officer (CSO) at Capnopharm GmbH, Germany. She has authored several research articles, book chapters, and presented her research in many national/international conferences. She has filed multiple patent applications in the area of drug delivery and targeting. Besides that, she has edited many trending books in the area of pharmaceutical nanotechnology and drug delivery aspects. For her research, she has received many prestigious national and international awards among them include recently received prestigious German Innovation Award 2022. Her areas of interest include polymeric nanoparticles, nanocrystals, lipid nanoparticles (SLNs/NLCs), nanoemulsions, cancer drug targeting and the role of excipients in delivery systems. (www.ranjitas.com)
